Virosomes: Evolution of the liposome as a targeted drug delivery system

Advanced Drug Delivery Reviews

Volumn 43, Issue 2-3, 2000, Pages 197-205

  Kaneda, Yasufumi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Gene therapy; Gene transfer; Tissue targeting; Viral protein; Virosomes

Indexed keywords

ANTIBODIES; GENE TRANSFER; LIPIDS; ONCOLOGY; TISSUE;

GENE THERAPY; TISSUE TARGETING; VIRAL PROTEINS; VIROSOMES;

DRUG THERAPY;

ANTIBODY; LIGAND; LIPOSOME; UNCLASSIFIED DRUG; VIROSOME; VIRUS PROTEIN; VIRUS VECTOR;

CANCER; CHEMICAL MODIFICATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TARGETING; DRUG UPTAKE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; MONOGENIC DISORDER; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; REVIEW; TARGET ORGAN;

EID: 0034734990     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00069-7     Document Type: Article

References (51)

1. Ledley F.D. Non-viral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6:1995;1129-1144.
2. Bangham A.D., Standish M.M., Watkins J.C. Diffusion of univalent ions across the lamella of swollen phospholipids. J. Mol. Biol. 13:1965;238-252.
3. Gregoriadis G. Liposomes as Drug Carriers: Recent Trends and Progress. 1988;Wiley, Chichester.
4. Bertling W.M., Gareis M., Paspaleeva V., Zimmer A., Kreuter J., Numberg E., Harrer P. Use of liposomes, viral capsids, and nanoparticles as DNA carriers. Biotechnol. Appl. Biochem. 13:1991;390-405.
5. Legendre J.Y., Szoka F.C. Jr. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm. Res. 9:1992;1235-1242.
6. Alving C.R., Steck E.A., Chapman W.L. Jr., Waits V.W., Hendricks L.D., Swarts G.M., Hanson W.L. Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc. Natl. Acad. Sci. USA. 75:1978;2959-2963.
7. Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., Fidler I.J. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res. 42:1982;1412-1422.
8. Fidler I.J., Raz A., Fogler W.E., Kirsh R., Bugalski P., Poste G. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res. 40:1980;4460-4466.
9. Allen T.M., Williamson P., Schlegel R.A. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome model of the erythrocyte surface. Proc. Natl. Acad. Sci. USA. 85:1988;8067-8071.
10. Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA. 85:1988;6949-6953.
11. Schaeffer-Ridder M., Wang Y., Hofschneider P.H. Liposomes as gene carriers; Efficient transformation of mouse L cells by thymidine kinase. Science. 215:1982;215-217.
12. Nicolau C., Pape A.L., Soriano P., Fargette F., Juhel M.-F. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc. Natl. Acad. Sci. USA. 80:1983;1068-1072.
13. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.S., Wenz M., Northrop J.P., Ringold G.M., Danielsen H. Lipofection; a highly efficient lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
14. Gao X., Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:1991;280-285.
15. Nabel G.J., Nabel E.G., Yang Z.Y., Fox B.A., Plautz G.E., Gao X., Huang L., Shu S., Gordon D., Chang A.E. Direct gene transfer with DNA-liposome complexes in melanoma; Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA. 90:1993;11307-11310.
16. Alton E.W.F.W., Middeleton P.G., Caplen N.J., Smith S.N., Steel D.M., Munkonge F.M., Jeffery P.K., Geddes D.M., Hart S.L., Williamson R., Fasoud K.I., Miller A.D., Dickinson P., Stevenson B.J., mcLachlin G., Dorin J.R., Porteous D.J. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nature Genet. 5:1993;135-142.
17. Caplen N.J., Alton E.W.F.W., Middleton P.G. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1:1995;39-46.
18. San H., Yang Z.-Y., Pompili V.J., Jaffe M.L., Plautz G.E., Xu L., Felgner J.H., Wheeler C.J., Felgner P.L., Gao X., Huang L., Gordon D., Nabel G.J., Nabel E.G. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum. Gene Ther. 4:1993;781-788.
19. Wheeler C.J., Felgner P.L., Tsai Y.J., Marshall J., Sukhu L., Doh S.G., Hartikka J., Nietupski J., Manthorpe M., Nichols M., Plewe M., Liang X., Norman J., Smith A., Cheng S.H. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA. 93:1996;11454-11459.
20. Koshizaka T., Hayashi Y., Yagi K. Novel liposomes for efficient transfection of beta-galactosidase gene into COS-1 cells. J. Clin. Biochem. Nutr. 7:1989;185-192.
21. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
22. Martin F.J., Papahadjopoulos D. Irreversible coupling of immunoglobulin fragments to preformed vesicles. J. Biol. Chem. 257:1982;286-288.
23. Leserman L.D., Barbet J., Kourilsky F. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature. 288:1980;602-604.
24. Mizuno M., Yoshida J., Sugita K., Inoue I., Seo H., Hayashi Y., Koshizaka T., Yagi K. Growth inhibition of glioma cells transfected with human beta-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res. 50:1990;7826-7829.
25. Machy P., Lewis F., McMillan L., Jonak Z.L. Gene transfer from targeted liposomes to specific lymphoid cells by electroporation. Proc. Natl. Acad. Sci. USA. 85:1988;8027-8031.
26. Wu G.Y., Wu C.H. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263:1988;14621-14624.
27. Zenke M., Steinlein P., Wagner E., Cotten M., Beug H., Birnstiel M.L. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc. Natl. Acad. Sci. USA. 87:1990;3655-3659.
28. Kaneda Y., Saeki Y., Morishita R. Gene therapy using HVJ-liposomes; the best of both worlds? Mol. Med. Today. 5:1999;298-303.
29. Okada Y. Sendai-virus induced cell fusion. Duzugnes N. Methods in Enzymology. Vol. 221:1993;18-41 Academic Press, Inc, San Diego.
30. Morishita R., Gibbons G.H., Kaneda Y., Ogihara T., Dzau V.J. Pharmacokinetics of antisense oligonucleotides (cyclin B1 and cdc 2 kinase) in the vessel wall: enhanced therapeutic utility for restenosis by HVJ-liposome method. Gene. 149:1994;3-9.
31. Suzuki K., Nakashima H., Sawa Y., Morishita R., Matsuda H., Kaneda Y. Reconstituted fusion liposomes for gene transfer in vitro and in vivo. Gene Ther. Reg. 1:2000;1-13.
32. Hirano T., Fujimoto J., Ueki T., Yamamoto H., Iwasaki T., Morishita R., Sawa Y., Kaneda Y., Takahashi H., Okamoto E. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. Gene Ther. 5:1998;459-464.
33. Ramani K., Bora R.S., Kumar M., Tyagi S.K., Sarkar D.P. Novel gene delivery to liver cells using engineered virosomes. FEBS Lett. 404:1997;164-168.
34. Ramani K., Hassan Q., Venkaiah B., Hasnain S.E., Sarkar D.P. Site-specific gene delivery in vivo through engineered Sendai viral envelopes. Proc. Natl. Acad. Sci. USA. 95:1998;11886-11890.
35. Saeki Y., Matsumoto N., Nakano Y., Mori M., Awai K., Kaneda Y. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus); reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum. Gene Ther. 8:1997;1965-1972.
36. Kitajima I., Hanyu N., Soejima Y., Hirano T., Arahira S., Yamaoka S., Yamada R., Maruyama I., Kaneda Y. Efficient transfer of synthetic ribozymes into cells using hemagglutinating virus of Japan (HVJ)-cationic liposomes; application for ribozymes that target HTLV-1 tax/rex mRNA. J. Biol. Chem. 272:1997;27099-27106.
37. Chander R., Schreier H. Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160. Life Science. 50:1992;481-489.
38. Yamada G., Nakamura S., Haraguchi R., Sakai M., Terashi T., Sakisaka S., Toyoda T., Ogino Y., Hatanaka H., Kaneda Y. An efficient liposome-mediated gene transfer into the bronchial arch, neural tube and the heart of chick embryos: a strategy to elucidate organogenesis. Cell. Mol. Biol. 43:1997;1165-1169.
39. Yonemitsu Y., Kaneda Y., Muraishi A., Yoshizumi T., Sugimachi K., Sueishi K. HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated gene transfer technique to the delivery to the airway epithelium. Gene Ther. 4:1997;631-638.
40. Schoen P., Chonn A., Cullis P.R., Wilschut J., Scherrer P. Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles. Gene Ther. 6:1999;823-832.
41. DNA tumor viruses. Tooze J. Molecular Biology of Tumor Viruses. 1981;Cold Spring Harbor Laboratory, New York. Part 2.
42. Burns J.C., Friedmann T., Driever W., Burrascano M., Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotype retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc. Natl. Acad. Sci. USA. 90:1993;8033-8037.
43. Flint S.J., Enquist L.W., Krug R.M., Racaniello V.R., Skalka A.M. Principles of Virology. 2000;ASM Press, Washington D.C.
44. Chander R., Schreier H. Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160. Life Sci. 50:1992;481-489.
45. Schreier H., Mora P., Caras I.W. Targeting liposomes to cells expressing CD4 using glycosylphosphatidylinositol-anchored gp120. Influence of liposome composition on intracellular trafficking. J. Biol. Chem. 269:1994;9090-9098.
46. de Bruin W.C., Hertogs K., Leenders W.P., Depla E., Yap S.H. Hepatitis B virus: Specific binding and internalization of small HBsAg by human hepatocytes. J. Gen. Virol. 76:1995;1047-1050.
47. de Bruin W.C., Leenders W.P., Moshage H., Haelst U.J. Species specificity for HBsAg binding protein endonexin II. J. Hepatol. 24:1996;265-270.
48. Gall J., Kass-Eisler A., Leinwand L., Falck-Pederson E. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 70:1996;2116-2123.
49. Krasnykh V.N., Mikheeva G.V., Douglas J.T., Curiel D.T. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70:1996;6839-6846.
50. Zabner J., Chillon M., Grunst T., Moninger T.O., Davidson B.L., Gregory R., Armentano D. A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. J. Virol. 73:1999;8689-8695.
51. Von Seggern D.J., Huang S., Fleck S.K., Stevenson S.C., Nemerow G.R. Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J. Virol. 74:2000;354-362.